Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital.
Scand J Rheumatol
; 34(5): 353-8, 2005.
Article
in En
| MEDLINE
| ID: mdl-16234182
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Immunoglobulin G
/
Receptors, Tumor Necrosis Factor
/
Antirheumatic Agents
/
Antibodies, Monoclonal
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Scand J Rheumatol
Year:
2005
Document type:
Article
Affiliation country:
Sweden